Examkin

Soru

Zorluk: KolayNeurocognitive Disorders

A primary care physician is evaluating a 74-year-old patient who presents with her son for a routine wellness visit. The son mentions that his mother has been repeatedly asking the same questions and occasionally getting lost in familiar neighborhoods over the past year. Arrange the following steps in the most appropriate chronological order for the standard clinical evaluation and management of this patient's suspected cognitive impairment.

  1. 1Obtain a detailed clinical history, including a medication review and collateral information from the son.
  2. 2Administer a standardized objective cognitive screening test, such as the Montreal Cognitive Assessment (MoCA).
  3. 3Order routine laboratory tests (e.g., TSH, vitamin B12) and structural neuroimaging (e.g., MRI of the brain).
  4. 4Establish a definitive diagnosis and discuss the initiation of symptomatic pharmacological therapy, if indicated.

Cevap

The correct sequence begins with obtaining a detailed history and medication review, followed by formal cognitive testing, then ruling out reversible causes with laboratory tests and neuroimaging, and finally establishing a diagnosis to guide therapy.
The standard diagnostic approach to a patient presenting with cognitive decline follows a stepwise progression to ensure accurate diagnosis while minimizing unnecessary testing. The evaluation begins with a thorough clinical history and medication review to identify obvious reversible factors, such as polypharmacy. Next, an objective cognitive screening tool (like the MoCA or MMSE) must be administered to document the presence and severity of the cognitive deficit. Once cognitive impairment is established, the clinician orders laboratory tests (including TSH and Vitamin B12) and structural neuroimaging (such as a brain MRI) to exclude reversible systemic or structural etiologies (e.g., normal pressure hydrocephalus, vascular dementia, or tumors). Finally, after reversible causes have been ruled out and a specific neurocognitive disorder (e.g., Alzheimer disease) is diagnosed, a management plan involving symptomatic pharmacotherapy can be initiated.

Adım Adım Çözüm

1
Obtain history and perform a medication review with collateral information.
Identifies the timeline of symptoms and potential iatrogenic contributors.
This is the fundamental first step in any patient evaluation to guide subsequent testing.
2
Administer an objective cognitive screen (e.g., MoCA or MMSE).
Quantifies the degree of cognitive impairment.
Objective evidence of cognitive decline is required before pursuing an expensive or invasive diagnostic workup.
3
Order laboratory tests (TSH, B12, CMP, CBC) and structural neuroimaging.
Rules out reversible causes of dementia.
Major neurocognitive disorder is largely a diagnosis of exclusion; reversible systemic or structural causes must be investigated.
4
Establish the diagnosis and initiate symptomatic treatment if appropriate.
Provides the patient and family with a management plan.
Therapies (such as cholinesterase inhibitors) can only be appropriately prescribed once the diagnosis is confirmed.

Anahtar Kavram

Diagnostic approach to neurocognitive disorders
Bu soruyu puanla

Konular

Neurocognitive Disorders

Bu konudan daha fazla soru